Literature DB >> 23598952

Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.

Eitan Kerem1, Laura Viviani, Anna Zolin, Stephanie MacNeill, Elpis Hatziagorou, Helmut Ellemunter, Pavel Drevinek, Vincent Gulmans, Uros Krivec, Hanne Olesen.   

Abstract

Pulmonary insufficiency is the main cause of death in cystic fibrosis (CF). We analysed forced expiratory volume in 1 s (FEV1) data of 14,732 patients registered in the European Cystic Fibrosis Society Patient Registry (ECFSPR) database in 2007. We used linear and logistic regressions to investigate associations between FEV1 % predicted and clinical outcomes. Body mass index (BMI), chronic infection by Pseudomonas aeruginosa, pancreatic status and CF-related diabetes (CFRD) showed a statistically significant (all p<0.0001) and clinically relevant effect on FEV1 % pred after adjusting for age. Patients with a lower BMI experience a six-fold increased odds ratio (95% CI 5.0-7.3) of having severe lung disease (FEV1 <40% pred) compared to patients with normal BMI. Being chronically infected with P. aeruginosa increases the odds ratio of severe lung disease by 2.4 (95% CI 2.0-2.7), and patients with pancreatic insufficiency experience a 2.0-fold increased odds ratio (95% CI 1.6-2.5) of severe lung disease compared to pancreatic sufficient patients. Patients with CFRD have a 1.8-fold increased odds ratio (95% CI 1.6-2.2) compared to patients not affected. These potential risk factors for pulmonary disease in patients with CF are to some degree preventable or treatable. We emphasise the importance of their early identification through frequent routine tests, the implementation of infection control measures, and a timely initiation of relevant therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23598952     DOI: 10.1183/09031936.00166412

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  82 in total

1.  Body composition and lung function in children with cystic fibrosis and meconium ileus.

Authors:  Artemis Doulgeraki; Argyri Petrocheilou; Glykeria Petrocheilou; George Chrousos; Stavros-Eleftherios Doudounakis; Athanasios G Kaditis
Journal:  Eur J Pediatr       Date:  2017-04-13       Impact factor: 3.183

Review 2.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

3.  Impact of T2R38 Receptor Polymorphisms on Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Andrew R Turnbull; Ronan Murphy; Volker Behrends; Helena Lund-Palau; Ameze Simbo; Myril Mariveles; Eric W F W Alton; Andrew Bush; Amelia Shoemark; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

4.  Age is a predictor of a small decrease in lung function in children with sickle cell anemia.

Authors:  Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

5.  Growth Deficiency in Cystic Fibrosis Is Observable at Birth and Predictive of Early Pulmonary Function.

Authors:  Rebecca Darrah; Rebecca Nelson; Elizabeth G Damato; Michael Decker; Anne Matthews; Craig A Hodges
Journal:  Biol Res Nurs       Date:  2016-04-13       Impact factor: 2.522

6.  The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

Authors:  Sladjana Skopelja; B JoNell Hamilton; Jonathan D Jones; Mei-Ling Yang; Mark Mamula; Alix Ashare; Alex H Gifford; William Fc Rigby
Journal:  JCI Insight       Date:  2016-10-20

7.  Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis.

Authors:  Tasma Harindhanavudhi; Qi Wang; Jordan Dunitz; Antoinette Moran; Amir Moheet
Journal:  J Cyst Fibros       Date:  2019-11-11       Impact factor: 5.482

Review 8.  [Evidence-based treatment of cystic fibrosis].

Authors:  F C Ringshausen; T Hellmuth; A-M Dittrich
Journal:  Internist (Berl)       Date:  2020-12       Impact factor: 0.743

Review 9.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

10.  Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.

Authors:  D H Limoli; J Yang; M K Khansaheb; B Helfman; L Peng; A A Stecenko; J B Goldberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.